Sanofi delivers Business EPS growth of 7.3% at CER in 2014
Annual results 2014 were reviewed by management during a conference call. The presentation was followed by a Q&A session.
Annual results 2014 were reviewed by management during a conference call. The presentation was followed by a Q&A session.
This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.